High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
about
FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapyOxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancerVascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathiesAn oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.Oxaliplatin with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (Modified FOLFOX 4) as first-line therapy for patients with metastatic colorectal cancer.Palliative treatment of patients with colorectal cancer.Metastatic colorectal cancer: systemic treatment in the new millennium.Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced DiarrheaEffect of leucovorin on the antitumor efficacy of the 5-FU prodrug, tegafur-uracil, in human colorectal cancer xenografts with various expression levels of thymidylate synthaseExcess weight among colorectal cancer survivors: target for intervention.Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patientsA 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer.Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderlyHypersensitivity reactions related to oxaliplatin (OHP).Bevacizumab in the therapy for refractory metastatic colorectal cancer.Phase II study of oxaliplatin, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as second line therapy.Combination chemotherapy of oxaliplatin, 5-fluorouracil and low dose leucovorin in patients with advanced colorectal cancer.Metastatic colorectal cancer: current treatment and future options for improved survival. Medical approach--present status.A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.Cell cycle arrest by oxaliplatin on cancer cells.Anti-cancer effects of xanthones from pericarps of mangosteen.Therapeutic strategy in unresectable metastatic colorectal cancer.UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancerA Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens.FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer.
P2860
Q26851060-8619F37E-2D0D-4FFD-A467-963AFB58FA6EQ28364999-784296B6-C366-4E1A-B38F-86AB29CB912EQ33324545-5750EF6F-5659-4E74-9206-0B0907B09BEDQ33341057-B607F063-331C-44B4-B2BD-C8198A3C2F55Q33378863-6C53C640-AAC6-4899-B1E1-9E9AB80D3D4DQ33389165-20899D5F-E315-45A2-9347-121F96FC9294Q35111182-BDA2CA16-AFAF-4E30-AA69-276B4A90F3CDQ35148795-AE132A08-B574-4F6B-8FA3-E4C6730B4C29Q35840388-BAF9FC98-8BB0-43BA-BB83-3EAC6552AE91Q36142392-517FF74E-3BFF-498F-B60F-B1CB7E886DA3Q36236792-259B03BA-B353-473A-99D1-675EABF8A9E9Q36616400-4F1A61A5-F1D9-448A-848C-783F557758F2Q36645980-8E254ED5-3AC1-472B-AEA6-32D594791ED7Q36671275-2A45595E-E14D-44B3-9757-833F77A494A9Q36671350-2AB408A0-9C97-4CBE-9D98-AEE47530DB81Q37307590-D0A5B9E0-40D1-45A9-B466-FBFF833E093EQ37341645-25AADBB4-7846-4B6C-96BF-8615E1310241Q37449224-4C83BA82-F17D-47C2-9C11-96D4C42B3021Q37975508-FBEF6E51-D829-44A8-9E0C-48AC28A57AE5Q39365352-E925CC43-7CB8-4F38-BDD2-2B12CEF79299Q40153241-87B3248C-FDB3-4132-B8BD-B5CB041068DAQ41765214-64118552-9F12-43D4-8973-13E339BA12AAQ42000639-D60FF8D7-8B1B-4B19-9DC2-92C9D0AC091BQ42600675-4F2190E5-6572-43AB-A580-91DE022FF16BQ43453266-1DC35AA6-EAF7-4935-B4E4-5CB2AB62B4D7Q43559620-6034E671-DFC3-4422-96D8-D5244FD43354Q44938504-B9004C05-B8EC-4694-8844-52C1A211CB2CQ46929599-309EA92A-FAA8-44C2-B12A-F55A19A8897DQ46990345-791261FE-09F1-44AB-B64E-90A9313466F2Q51320998-2BFE58BA-0235-4CD0-8667-C0EB0B8A1B32
P2860
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
High-dose intensity oxaliplati ...... colorectal cancer (FOLFOX 7).
@ast
High-dose intensity oxaliplati ...... colorectal cancer (FOLFOX 7).
@en
High-dose intensity oxaliplati ...... r metastatic colorectal cancer
@nl
type
label
High-dose intensity oxaliplati ...... colorectal cancer (FOLFOX 7).
@ast
High-dose intensity oxaliplati ...... colorectal cancer (FOLFOX 7).
@en
High-dose intensity oxaliplati ...... r metastatic colorectal cancer
@nl
prefLabel
High-dose intensity oxaliplati ...... colorectal cancer (FOLFOX 7).
@ast
High-dose intensity oxaliplati ...... colorectal cancer (FOLFOX 7).
@en
High-dose intensity oxaliplati ...... r metastatic colorectal cancer
@nl
P2093
P1476
High-dose intensity oxaliplati ...... colorectal cancer (FOLFOX 7).
@en
P2093
A de Gramont
F Maindrault-Goebel
Oncology Multidisciplinary Research Group (GERCOR)
P304
P356
10.1016/S0959-8049(01)00068-5
P50
P577
2001-05-01T00:00:00Z